Magle Chemoswed
Magle Chemoswed is an international contract development and manufacturing company (CDMO) whose customers are found in the pharmaceutical and medical equipment industry. The company is active throughout the value chain from development to manufacturing, which entails several synergies. In addition, the company develops its own product portfolio based on their technology platform, and then sells the products. The company was formed in 2017 when Magle Life Sciences acquired Chemoswed. Magle Chemoswed has been listed on Nasdaq First North Growth Market since 2020 (ticker: MAGLE).
Stock price
Company information
No Data Available